Sequentially administrated of pemetrexed with icotinib/erlotinib in lung adenocarcinoma cell lines in vitro

Combination of chemotherapy and epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) had been proved to be a potent anti-drug for the treatment of tumors. However, survival time was not extended for the patients with lung adenocarcinoma (AdC) compared with first-line chemotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Xiuli, Zhang, Yan, Li, Tao, Li, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768404/
https://www.ncbi.nlm.nih.gov/pubmed/29371987
http://dx.doi.org/10.18632/oncotarget.23224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768404/
https://www.ncbi.nlm.nih.gov/pubmed/29371987
http://dx.doi.org/10.18632/oncotarget.23224

Ejemplares similares